Endothelial Function in Women with and without a History of Glucose Intolerance in Pregnancy

Background/Aims. Gestational diabetes mellitus (GDM) and milder gestational impaired glucose tolerance (GIGT) identify women who are at risk of developing cardiovascular disease. Endothelial dysfunction, as indicated by impaired flow-mediated dilatation (FMD) on brachial artery ultrasound, is an ear...

Full description

Saved in:
Bibliographic Details
Main Authors: Shireen Brewster, John Floras, Bernard Zinman, Ravi Retnakaran
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/2013/382670
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832566895307390976
author Shireen Brewster
John Floras
Bernard Zinman
Ravi Retnakaran
author_facet Shireen Brewster
John Floras
Bernard Zinman
Ravi Retnakaran
author_sort Shireen Brewster
collection DOAJ
description Background/Aims. Gestational diabetes mellitus (GDM) and milder gestational impaired glucose tolerance (GIGT) identify women who are at risk of developing cardiovascular disease. Endothelial dysfunction, as indicated by impaired flow-mediated dilatation (FMD) on brachial artery ultrasound, is an early marker of vascular disease. Thus, we sought to evaluate endothelial function in women with and without recent glucose intolerance in pregnancy. Methods. One-hundred and seventeen women underwent oral glucose tolerance testing (OGTT) in pregnancy, enabling stratification into those with normal gestational glucose tolerance (n=59) and those with GDM or GIGT (n=58). 6 years postpartum, they underwent a repeat of OGTT and brachial artery FMD studies, enabling assessment of FMD and 4 secondary vascular measures: FMD after 60 seconds (FMD60), baseline arterial diameter, peak shear rate, and reactive hyperemia. Results. There were no differences between the normal gestational glucose tolerance and GDM/GIGT groups in FMD (mean 8.5 versus 9.3%, P=0.61), FMD60 (4.1 versus 5.1%, P=0.33), baseline diameter (3.4 versus 3.4 mm, P=0.66), peak shear rate (262.6 versus 274.8 s−1, P=0.32), and reactive hyperemia (576.6 versus 496.7%, P=0.07). After covariate adjustment, there were still no differences between the groups. Conclusion. Despite their long-term cardiovascular risk, women with glucose intolerance in pregnancy do not display endothelial dysfunction 6 years postpartum.
format Article
id doaj-art-578379dc16354e52aad0050640848e09
institution Kabale University
issn 2314-6745
2314-6753
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series Journal of Diabetes Research
spelling doaj-art-578379dc16354e52aad0050640848e092025-02-03T01:02:48ZengWileyJournal of Diabetes Research2314-67452314-67532013-01-01201310.1155/2013/382670382670Endothelial Function in Women with and without a History of Glucose Intolerance in PregnancyShireen Brewster0John Floras1Bernard Zinman2Ravi Retnakaran3Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto, ON, M5T 3L9, CanadaDivision of Cardiology, Mount Sinai Hospital, Toronto, ON, M5G 1X5, CanadaLeadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto, ON, M5T 3L9, CanadaLeadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto, ON, M5T 3L9, CanadaBackground/Aims. Gestational diabetes mellitus (GDM) and milder gestational impaired glucose tolerance (GIGT) identify women who are at risk of developing cardiovascular disease. Endothelial dysfunction, as indicated by impaired flow-mediated dilatation (FMD) on brachial artery ultrasound, is an early marker of vascular disease. Thus, we sought to evaluate endothelial function in women with and without recent glucose intolerance in pregnancy. Methods. One-hundred and seventeen women underwent oral glucose tolerance testing (OGTT) in pregnancy, enabling stratification into those with normal gestational glucose tolerance (n=59) and those with GDM or GIGT (n=58). 6 years postpartum, they underwent a repeat of OGTT and brachial artery FMD studies, enabling assessment of FMD and 4 secondary vascular measures: FMD after 60 seconds (FMD60), baseline arterial diameter, peak shear rate, and reactive hyperemia. Results. There were no differences between the normal gestational glucose tolerance and GDM/GIGT groups in FMD (mean 8.5 versus 9.3%, P=0.61), FMD60 (4.1 versus 5.1%, P=0.33), baseline diameter (3.4 versus 3.4 mm, P=0.66), peak shear rate (262.6 versus 274.8 s−1, P=0.32), and reactive hyperemia (576.6 versus 496.7%, P=0.07). After covariate adjustment, there were still no differences between the groups. Conclusion. Despite their long-term cardiovascular risk, women with glucose intolerance in pregnancy do not display endothelial dysfunction 6 years postpartum.http://dx.doi.org/10.1155/2013/382670
spellingShingle Shireen Brewster
John Floras
Bernard Zinman
Ravi Retnakaran
Endothelial Function in Women with and without a History of Glucose Intolerance in Pregnancy
Journal of Diabetes Research
title Endothelial Function in Women with and without a History of Glucose Intolerance in Pregnancy
title_full Endothelial Function in Women with and without a History of Glucose Intolerance in Pregnancy
title_fullStr Endothelial Function in Women with and without a History of Glucose Intolerance in Pregnancy
title_full_unstemmed Endothelial Function in Women with and without a History of Glucose Intolerance in Pregnancy
title_short Endothelial Function in Women with and without a History of Glucose Intolerance in Pregnancy
title_sort endothelial function in women with and without a history of glucose intolerance in pregnancy
url http://dx.doi.org/10.1155/2013/382670
work_keys_str_mv AT shireenbrewster endothelialfunctioninwomenwithandwithoutahistoryofglucoseintoleranceinpregnancy
AT johnfloras endothelialfunctioninwomenwithandwithoutahistoryofglucoseintoleranceinpregnancy
AT bernardzinman endothelialfunctioninwomenwithandwithoutahistoryofglucoseintoleranceinpregnancy
AT raviretnakaran endothelialfunctioninwomenwithandwithoutahistoryofglucoseintoleranceinpregnancy